# Shanmuga Hospit (NSE: SHANMUGA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SHANMUGA · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹48 Cr, it ranks 3100th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

Its return on equity was 9.9% in FY26. Promoters held 72.06% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹48 Cr |
| ROE | 9.9% (FY26) |
| ROCE | 12.8% (FY26) |
| Debt to equity | 0.16 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY26 | ₹17 Cr | ₹3 Cr |
| FY25 | ₹17 Cr | ₹4 Cr |
| FY24 | ₹14 Cr | ₹3 Cr |
| FY23 | ₹13 Cr | ₹4 Cr |
| FY22 | ₹13 Cr | ₹1 Cr |
| FY21 | ₹8 Cr | −₹1 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 72.06%
- Non-institutions: 27.94%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Shree Pacetroni](https://app.pivotnow.in/stock/SHREEPAC) | — | ₹50 Cr | — | — |
| [Biofil Chemicals & Pharmaceuticals](https://app.pivotnow.in/stock/BIOFILCHEM) | ₹30.00 | ₹49 Cr | 17.5 | — |
| [Mangalam Drugs And Organics](https://app.pivotnow.in/stock/MANGALAM) | ₹29.66 | ₹47 Cr | — | — |
| [Amkay Products](https://app.pivotnow.in/stock/AMKAY) | — | ₹46 Cr | — | — |
| [Shelter Pharma](https://app.pivotnow.in/stock/SHELTER) | — | ₹46 Cr | — | — |
| [Vista Pharma](https://app.pivotnow.in/stock/VISTAPH) | — | ₹45 Cr | — | — |

## Questions and answers

### What is the market cap of Shanmuga Hospit?

Shanmuga Hospit's market capitalisation is ₹48 Cr (₹48 Cr) at the 22 Oct 2026 close, ranking 3100th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Shanmuga Hospit?

Return on equity was 9.9% in FY26 and return on capital employed was 12.8% in FY26 (standalone figures).

### Is Shanmuga Hospit a debt-free company?

No. Shanmuga Hospit's debt-to-equity ratio was 0.16 in FY26, with total debt of ₹4 Cr.

### What is the shareholding pattern of Shanmuga Hospit?

As of 31 Mar 2026: promoters 72.06%, non-institutions 27.94%.

### Who are Shanmuga Hospit's competitors?

The listed Pharma & Healthcare companies closest to Shanmuga Hospit by market cap are Shree Pacetroni, Biofil Chemicals & Pharmaceuticals, Mangalam Drugs And Organics, Amkay Products, Shelter Pharma and Vista Pharma.

### Is Shanmuga Hospit a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Shanmuga Hospit's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SHANMUGA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.